[HTML][HTML] Organ-on-a-chip microengineering for bio-mimicking disease models and revolutionizing drug discovery

T Ahmed - Biosensors and Bioelectronics: X, 2022 - Elsevier
The core of the drug research and screening processes is predicting the effect of drugs prior
to human clinical trials. Due to the 2D cell culture and animal models' poor predictability, the …

The Expression of Proto-Oncogene ETS-Related Gene (ERG) Plays a Central Role in the Oncogenic Mechanism Involved in the Development and Progression of …

E Khosh Kish, M Choudhry, Y Gamallat… - International journal of …, 2022 - mdpi.com
The ETS-related gene (ERG) is proto-oncogene that is classified as a member of the ETS
transcription factor family, which has been found to be consistently overexpressed in about …

Converse modulation of Wnt/β-catenin signaling during expansion and differentiation phases of Infrapatellar fat pad-derived MSCs for improved engineering of …

A Mahajan, MA Nengroo, D Datta, DS Katti - Biomaterials, 2023 - Elsevier
Mesenchymal stem cells (MSCs) are potential candidates in cell-based therapy for cartilage
repair and regeneration. However, during chondrogenic differentiation, MSCs undergo …

Organs-on-Chips platforms are everywhere: A zoom on biomedical investigation

M Zommiti, N Connil, A Tahrioui, A Groboillot, C Barbey… - Bioengineering, 2022 - mdpi.com
Over the decades, conventional in vitro culture systems and animal models have been used
to study physiology, nutrient or drug metabolisms including mechanical and …

Mechanism-centric regulatory network identifies NME2 and MYC programs as markers of Enzalutamide resistance in CRPC

S Panja, MI Truica, CY Yu, V Saggurthi… - Nature …, 2024 - nature.com
Heterogeneous response to Enzalutamide, a second-generation androgen receptor
signaling inhibitor, is a central problem in castration-resistant prostate cancer (CRPC) …

Transcription networks rewire gene repertoire to coordinate cellular reprograming in prostate cancer

N Manzar, P Ganguly, UK Khan, B Ateeq - Seminars in Cancer Biology, 2023 - Elsevier
Transcription factors (TFs) represent the most commonly deregulated DNA-binding class of
proteins associated with multiple human cancers. They can act as transcriptional activators …

Transcriptome profiling of circulating tumor cells to predict clinical outcomes in metastatic castration-resistant prostate cancer

L Groen, I Kloots, D Englert, K Seto… - International Journal of …, 2023 - mdpi.com
The clinical utility of circulating tumor cells (CTC) as a non-invasive multipurpose biomarker
is broadly recognized. The earliest methods for enriching CTCs from whole blood rely on …

Epigenetic reprogramming during prostate cancer progression: a perspective from development

S Goel, V Bhatia, T Biswas, B Ateeq - Seminars in cancer biology, 2022 - Elsevier
Conrad Waddington's theory of epigenetic landscape epitomize the process of cell fate and
cellular decision-making during development. Wherein the epigenetic code maintains …

MYCN Amplifications and Metabolic Rewiring in Neuroblastoma

M Pouliou, MA Koutsi, L Champezou, AI Giannopoulou… - Cancers, 2023 - mdpi.com
Simple Summary Transcription factors (TFs) can reprogram cellular states by modulating the
expression of their target genes and establishing gene expression programs under …

An overview of siRNA delivery strategies for urological cancers

N Halib, N Pavan, C Trombetta, B Dapas, R Farra… - Pharmaceutics, 2022 - mdpi.com
The treatment of urological cancers has been significantly improved in recent years.
However, for the advanced stages of these cancers and/or for those developing resistance …